Selected research
Market Analysis & Forecast
Global Medical Diagnostic Software Market Analysis and Forecast 2026-2032
Market perspective
The global Medical Diagnostic Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Medical Diagnostic Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Medical Diagnostic Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Medical Diagnostic Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Medical Diagnostic Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Medical Diagnostic Software include Osplabs, CrelioHealth, Human Dx, Empeek, Folio3 AI, Isabel Healthcare, SysGears, PC Connection and Folio3, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Medical Diagnostic Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Medical Diagnostic Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Diagnostic Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Diagnostic Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Diagnostic Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Diagnostic Software revenue, projected growth trends, production technology, application and end-user industry.
Medical Diagnostic Software Segment by Company
Osplabs
CrelioHealth
Human Dx
Empeek
Folio3 AI
Isabel Healthcare
SysGears
PC Connection
Folio3
PathAI
Nanox Imaging(Zebra Medical Vision)
DreaMed Diabetes
Healthvisors
Butterfly Network
Ada Health
Buoy Health
Medical Diagnostic Software Segment by Type
Medical Imaging-Assisted Diagnostic Software
Physiological Signal Analysis Diagnostic Software
Laboratory Data-Assisted Diagnostic Software
Clinical Decision Support System (CDSS)
Medical Diagnostic Software Segment by Application
Hospital
Clinic
Others
Medical Diagnostic Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Diagnostic Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Diagnostic Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Diagnostic Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Medical Diagnostic Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Diagnostic Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Diagnostic Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Imaging-Assisted Diagnostic Software
- Physiological Signal Analysis Diagnostic Software
- Laboratory Data-Assisted Diagnostic Software
- Clinical Decision Support System (CDSS)
Applications
- Hospital
- Clinic
- Others
Companies covered
- Osplabs
- CrelioHealth
- Human Dx
- Empeek
- Folio3 AI
- Isabel Healthcare
- SysGears
- PC Connection
- Folio3
- PathAI
- Nanox Imaging(Zebra Medical Vision)
- DreaMed Diabetes
- Healthvisors
- Butterfly Network
- Ada Health
- Buoy Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Medical Diagnostic Software Market by Type
- 1.2.1 Global Medical Diagnostic Software Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Medical Imaging-Assisted Diagnostic Software
- 1.2.3 Physiological Signal Analysis Diagnostic Software
- 1.2.4 Laboratory Data-Assisted Diagnostic Software
- 1.2.5 Clinical Decision Support System (CDSS)
- 1.3 Medical Diagnostic Software Market by Application
- 1.3.1 Global Medical Diagnostic Software Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Diagnostic Software Market Dynamics
- 2.1 Medical Diagnostic Software Industry Trends
- 2.2 Medical Diagnostic Software Industry Drivers
- 2.3 Medical Diagnostic Software Industry Opportunities and Challenges
- 2.4 Medical Diagnostic Software Industry Restraints
3 Global Growth Perspective
- 3.1 Global Medical Diagnostic Software Market Perspective (2021-2032)
- 3.2 Global Medical Diagnostic Software Growth Trends by Region
- 3.2.1 Global Medical Diagnostic Software Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Medical Diagnostic Software Market Size by Region (2021-2026)
- 3.2.3 Global Medical Diagnostic Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Medical Diagnostic Software Revenue by Players
- 4.1.1 Global Medical Diagnostic Software Revenue by Players (2021-2026)
- 4.1.2 Global Medical Diagnostic Software Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Medical Diagnostic Software Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Medical Diagnostic Software Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Medical Diagnostic Software Key Players Headquarters & Area Served
- 4.4 Global Medical Diagnostic Software Players, Product Type & Application
- 4.5 Global Medical Diagnostic Software Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Medical Diagnostic Software Market CR5 and HHI
- 4.6.3 2025 Medical Diagnostic Software Tier 1, Tier 2, and Tier 3
5 Medical Diagnostic Software Market Size by Type
- 5.1 Global Medical Diagnostic Software Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Medical Diagnostic Software Revenue by Type (2021-2032)
- 5.3 Global Medical Diagnostic Software Revenue Market Share by Type (2021-2032)
6 Medical Diagnostic Software Market Size by Application
- 6.1 Global Medical Diagnostic Software Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Medical Diagnostic Software Revenue by Application (2021-2032)
- 6.3 Global Medical Diagnostic Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Osplabs
- 7.1.1 Osplabs Company Information
- 7.1.2 Osplabs Business Overview
- 7.1.3 Osplabs Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.1.4 Osplabs Medical Diagnostic Software Product Portfolio
- 7.1.5 Osplabs Recent Developments
- 7.2 CrelioHealth
- 7.2.1 CrelioHealth Company Information
- 7.2.2 CrelioHealth Business Overview
- 7.2.3 CrelioHealth Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.2.4 CrelioHealth Medical Diagnostic Software Product Portfolio
- 7.2.5 CrelioHealth Recent Developments
- 7.3 Human Dx
- 7.3.1 Human Dx Company Information
- 7.3.2 Human Dx Business Overview
- 7.3.3 Human Dx Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.3.4 Human Dx Medical Diagnostic Software Product Portfolio
- 7.3.5 Human Dx Recent Developments
- 7.4 Empeek
- 7.4.1 Empeek Company Information
- 7.4.2 Empeek Business Overview
- 7.4.3 Empeek Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.4.4 Empeek Medical Diagnostic Software Product Portfolio
- 7.4.5 Empeek Recent Developments
- 7.5 Folio3 AI
- 7.5.1 Folio3 AI Company Information
- 7.5.2 Folio3 AI Business Overview
- 7.5.3 Folio3 AI Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.5.4 Folio3 AI Medical Diagnostic Software Product Portfolio
- 7.5.5 Folio3 AI Recent Developments
- 7.6 Isabel Healthcare
- 7.6.1 Isabel Healthcare Company Information
- 7.6.2 Isabel Healthcare Business Overview
- 7.6.3 Isabel Healthcare Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.6.4 Isabel Healthcare Medical Diagnostic Software Product Portfolio
- 7.6.5 Isabel Healthcare Recent Developments
- 7.7 SysGears
- 7.7.1 SysGears Company Information
- 7.7.2 SysGears Business Overview
- 7.7.3 SysGears Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.7.4 SysGears Medical Diagnostic Software Product Portfolio
- 7.7.5 SysGears Recent Developments
- 7.8 PC Connection
- 7.8.1 PC Connection Company Information
- 7.8.2 PC Connection Business Overview
- 7.8.3 PC Connection Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.8.4 PC Connection Medical Diagnostic Software Product Portfolio
- 7.8.5 PC Connection Recent Developments
- 7.9 Folio3
- 7.9.1 Folio3 Company Information
- 7.9.2 Folio3 Business Overview
- 7.9.3 Folio3 Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.9.4 Folio3 Medical Diagnostic Software Product Portfolio
- 7.9.5 Folio3 Recent Developments
- 7.10 Google
- 7.10.1 Google Company Information
- 7.10.2 Google Business Overview
- 7.10.3 Google Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.10.4 Google Medical Diagnostic Software Product Portfolio
- 7.10.5 Google Recent Developments
- 7.11 PathAI
- 7.11.1 PathAI Company Information
- 7.11.2 PathAI Business Overview
- 7.11.3 PathAI Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.11.4 PathAI Medical Diagnostic Software Product Portfolio
- 7.11.5 PathAI Recent Developments
- 7.12 Nanox Imaging(Zebra Medical Vision)
- 7.12.1 Nanox Imaging(Zebra Medical Vision) Company Information
- 7.12.2 Nanox Imaging(Zebra Medical Vision) Business Overview
- 7.12.3 Nanox Imaging(Zebra Medical Vision) Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.12.4 Nanox Imaging(Zebra Medical Vision) Medical Diagnostic Software Product Portfolio
- 7.12.5 Nanox Imaging(Zebra Medical Vision) Recent Developments
- 7.13 DreaMed Diabetes
- 7.13.1 DreaMed Diabetes Company Information
- 7.13.2 DreaMed Diabetes Business Overview
- 7.13.3 DreaMed Diabetes Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.13.4 DreaMed Diabetes Medical Diagnostic Software Product Portfolio
- 7.13.5 DreaMed Diabetes Recent Developments
- 7.14 Healthvisors
- 7.14.1 Healthvisors Company Information
- 7.14.2 Healthvisors Business Overview
- 7.14.3 Healthvisors Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.14.4 Healthvisors Medical Diagnostic Software Product Portfolio
- 7.14.5 Healthvisors Recent Developments
- 7.15 Butterfly Network
- 7.15.1 Butterfly Network Company Information
- 7.15.2 Butterfly Network Business Overview
- 7.15.3 Butterfly Network Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.15.4 Butterfly Network Medical Diagnostic Software Product Portfolio
- 7.15.5 Butterfly Network Recent Developments
- 7.16 Ada Health
- 7.16.1 Ada Health Company Information
- 7.16.2 Ada Health Business Overview
- 7.16.3 Ada Health Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.16.4 Ada Health Medical Diagnostic Software Product Portfolio
- 7.16.5 Ada Health Recent Developments
- 7.17 Buoy Health
- 7.17.1 Buoy Health Company Information
- 7.17.2 Buoy Health Business Overview
- 7.17.3 Buoy Health Medical Diagnostic Software Revenue and Gross Margin (2021-2026)
- 7.17.4 Buoy Health Medical Diagnostic Software Product Portfolio
- 7.17.5 Buoy Health Recent Developments
8 North America
- 8.1 North America Medical Diagnostic Software Revenue (2021-2032)
- 8.2 North America Medical Diagnostic Software Revenue by Type (2021-2032)
- 8.2.1 North America Medical Diagnostic Software Revenue by Type (2021-2026)
- 8.2.2 North America Medical Diagnostic Software Revenue by Type (2027-2032)
- 8.3 North America Medical Diagnostic Software Revenue Share by Type (2021-2032)
- 8.4 North America Medical Diagnostic Software Revenue by Application (2021-2032)
- 8.4.1 North America Medical Diagnostic Software Revenue by Application (2021-2026)
- 8.4.2 North America Medical Diagnostic Software Revenue by Application (2027-2032)
- 8.5 North America Medical Diagnostic Software Revenue Share by Application (2021-2032)
- 8.6 North America Medical Diagnostic Software Revenue by Country
- 8.6.1 North America Medical Diagnostic Software Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Medical Diagnostic Software Revenue by Country (2021-2026)
- 8.6.3 North America Medical Diagnostic Software Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Medical Diagnostic Software Revenue (2021-2032)
- 9.2 Europe Medical Diagnostic Software Revenue by Type (2021-2032)
- 9.2.1 Europe Medical Diagnostic Software Revenue by Type (2021-2026)
- 9.2.2 Europe Medical Diagnostic Software Revenue by Type (2027-2032)
- 9.3 Europe Medical Diagnostic Software Revenue Share by Type (2021-2032)
- 9.4 Europe Medical Diagnostic Software Revenue by Application (2021-2032)
- 9.4.1 Europe Medical Diagnostic Software Revenue by Application (2021-2026)
- 9.4.2 Europe Medical Diagnostic Software Revenue by Application (2027-2032)
- 9.5 Europe Medical Diagnostic Software Revenue Share by Application (2021-2032)
- 9.6 Europe Medical Diagnostic Software Revenue by Country
- 9.6.1 Europe Medical Diagnostic Software Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Medical Diagnostic Software Revenue by Country (2021-2026)
- 9.6.3 Europe Medical Diagnostic Software Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Medical Diagnostic Software Revenue (2021-2032)
- 10.2 China Medical Diagnostic Software Revenue by Type (2021-2032)
- 10.2.1 China Medical Diagnostic Software Revenue by Type (2021-2026)
- 10.2.2 China Medical Diagnostic Software Revenue by Type (2027-2032)
- 10.3 China Medical Diagnostic Software Revenue Share by Type (2021-2032)
- 10.4 China Medical Diagnostic Software Revenue by Application (2021-2032)
- 10.4.1 China Medical Diagnostic Software Revenue by Application (2021-2026)
- 10.4.2 China Medical Diagnostic Software Revenue by Application (2027-2032)
- 10.5 China Medical Diagnostic Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Medical Diagnostic Software Revenue (2021-2032)
- 11.2 Asia Medical Diagnostic Software Revenue by Type (2021-2032)
- 11.2.1 Asia Medical Diagnostic Software Revenue by Type (2021-2026)
- 11.2.2 Asia Medical Diagnostic Software Revenue by Type (2027-2032)
- 11.3 Asia Medical Diagnostic Software Revenue Share by Type (2021-2032)
- 11.4 Asia Medical Diagnostic Software Revenue by Application (2021-2032)
- 11.4.1 Asia Medical Diagnostic Software Revenue by Application (2021-2026)
- 11.4.2 Asia Medical Diagnostic Software Revenue by Application (2027-2032)
- 11.5 Asia Medical Diagnostic Software Revenue Share by Application (2021-2032)
- 11.6 Asia Medical Diagnostic Software Revenue by Country
- 11.6.1 Asia Medical Diagnostic Software Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Medical Diagnostic Software Revenue by Country (2021-2026)
- 11.6.3 Asia Medical Diagnostic Software Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Medical Diagnostic Software Revenue (2021-2032)
- 12.2 SAMEA Medical Diagnostic Software Revenue by Type (2021-2032)
- 12.2.1 SAMEA Medical Diagnostic Software Revenue by Type (2021-2026)
- 12.2.2 SAMEA Medical Diagnostic Software Revenue by Type (2027-2032)
- 12.3 SAMEA Medical Diagnostic Software Revenue Share by Type (2021-2032)
- 12.4 SAMEA Medical Diagnostic Software Revenue by Application (2021-2032)
- 12.4.1 SAMEA Medical Diagnostic Software Revenue by Application (2021-2026)
- 12.4.2 SAMEA Medical Diagnostic Software Revenue by Application (2027-2032)
- 12.5 SAMEA Medical Diagnostic Software Revenue Share by Application (2021-2032)
- 12.6 SAMEA Medical Diagnostic Software Revenue by Country
- 12.6.1 SAMEA Medical Diagnostic Software Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Medical Diagnostic Software Revenue by Country (2021-2026)
- 12.6.3 SAMEA Medical Diagnostic Software Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst